Forte Biosciences, Inc. reports

Company location: Dallas, TX
Fiscal year end: 31 December

Forte Biosciences, Inc. has filed 625 SEC EDGAR filings since 16 Nov 2007

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 176-200 of 612 matching filings.

Per page

25

Current page

8

4

FORM 4 SUBMISSION

Filing date: 20 Dec 2023
Reporting date: 18 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Dec 2023
Reporting date: 13 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 12 Dec 2023
Reporting date: 11 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Dec 2023
Reporting date: 07 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38052

8-K

Filing date: 08 Dec 2023
Reporting date: 04 Dec 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 22 Nov 2023
Reporting date: 20 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-38052

10-Q

Filing date: 13 Nov 2023
Reporting date: 30 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Oct 2023
Reporting date: 01 Oct 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Oct 2023
Reporting date: 01 Oct 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Oct 2023
Reporting date: 01 Oct 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K/A File 001-38052

8-K/A

Filing date: 26 Sep 2023
Reporting date: 19 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 20 Sep 2023
Reporting date: 19 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 20 Sep 2023
Reporting date: 19 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 20 Sep 2023
Reporting date: 19 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 20 Sep 2023
Reporting date: 19 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 20 Sep 2023
Reporting date: 19 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 20 Sep 2023
Reporting date: 19 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 20 Sep 2023
Reporting date: 19 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38052

8-K

Filing date: 20 Sep 2023
Reporting date: 19 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38052

8-K

Filing date: 20 Sep 2023
Reporting date: 14 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13D/A File 005-89959

SC 13D/A filing

Filing date: 15 Sep 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DFAN14A File 001-38052

DFAN14A filing

Filing date: 14 Sep 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-89959

FORTE BIOSCIENCES, INC.

Filing date: 12 Sep 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-274257

EFFECT filing

Filing date: 08 Sep 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

424B3 File 333-274257

424B3

Filing date: 08 Sep 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .